NO20031141L - Nye forbindelser - Google Patents

Nye forbindelser

Info

Publication number
NO20031141L
NO20031141L NO20031141A NO20031141A NO20031141L NO 20031141 L NO20031141 L NO 20031141L NO 20031141 A NO20031141 A NO 20031141A NO 20031141 A NO20031141 A NO 20031141A NO 20031141 L NO20031141 L NO 20031141L
Authority
NO
Norway
Prior art keywords
new connections
polypeptides
methods
genes listed
polymicleotides
Prior art date
Application number
NO20031141A
Other languages
English (en)
Other versions
NO20031141D0 (no
Inventor
Pankaj Agarwal
John P Cogswell
Ying-Ta Lai
Shelby A Martensen
Randall F Smith
Jay C Strum
Qing Xie
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO20031141D0 publication Critical patent/NO20031141D0/no
Publication of NO20031141L publication Critical patent/NO20031141L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Polypeptider og polynukleotider av genene som er angitt i tabell I og fremgangsmåter til fremstilling av slike polypeptider ved rekombinante fremgangsmåter er beskrevet. Fremgangsmåter til anvendelse av polypeptider og polymikleotider av genene som er angitt i tabell I i diagnostiske analyser er også beskrevet.
NO20031141A 2000-09-13 2003-03-12 Nye forbindelser NO20031141L (no)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US23246300P 2000-09-13 2000-09-13
US23245500P 2000-09-13 2000-09-13
US23729300P 2000-10-02 2000-10-02
US24626900P 2000-11-07 2000-11-07
US25204900P 2000-11-20 2000-11-20
PCT/US2001/028462 WO2002022802A1 (en) 2000-09-13 2001-09-13 Novel compounds

Publications (2)

Publication Number Publication Date
NO20031141D0 NO20031141D0 (no) 2003-03-12
NO20031141L true NO20031141L (no) 2003-05-09

Family

ID=27540000

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031141A NO20031141L (no) 2000-09-13 2003-03-12 Nye forbindelser

Country Status (16)

Country Link
US (1) US20070238151A1 (no)
EP (1) EP1317538A4 (no)
JP (1) JP2004508825A (no)
KR (1) KR20030033055A (no)
CN (2) CN1474869A (no)
AU (2) AU9261901A (no)
BR (1) BR0113820A (no)
CA (1) CA2421303A1 (no)
CZ (1) CZ2003722A3 (no)
HU (1) HUP0400016A3 (no)
IL (1) IL154725A (no)
MX (1) MXPA03002180A (no)
NO (1) NO20031141L (no)
NZ (2) NZ534259A (no)
PL (1) PL361691A1 (no)
WO (1) WO2002022802A1 (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7339033B2 (en) * 1998-06-26 2008-03-04 Genentech, Inc. Pro1481
CN1633498A (zh) 2000-04-21 2005-06-29 武田药品工业株式会社 新型胰岛素/胰岛素样生长因子/松弛素家族多肽及其dna
US20030166522A1 (en) * 2000-12-12 2003-09-04 Ketchum Karen A. Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
CN1252257C (zh) * 2001-03-02 2006-04-19 复旦大学 人类g型溶菌酶、其编码序列、制法及用途
US7223558B2 (en) 2001-07-11 2007-05-29 Bristol-Myers Squibb Company Polynucleotides encoding three novel human cell surface proteins with leucine rich repeats and immunologobulin folds, BGS2, 3, and 4 and variants thereof
US7396662B2 (en) * 2001-12-19 2008-07-08 Immunex Corporation C-type lectin polypeptides
EP1504027A4 (en) * 2002-04-26 2005-06-01 Zymogenetics Inc PROTEIN ZACRP8 PARENT ADIPOCYTE COMPLEMENT
AU2002952993A0 (en) * 2002-11-29 2002-12-12 The Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland Therapeutic and diagnostic agents
EP2902491A1 (en) 2003-03-19 2015-08-05 Biogen MA Inc. NOGO receptor binding protein
WO2004087194A2 (en) * 2003-03-31 2004-10-14 Develogen Aktiengesellschaft Use of a dg931 protein for treating diabetes, obesity and metabolic syndrome
JP2007527692A (ja) * 2003-05-21 2007-10-04 アレス トレイディング ソシエテ アノニム Tnf様分泌タンパク質
EP1636384A4 (en) * 2003-06-20 2007-03-07 Amgen Inc GENEAVIFICATION AND OVEREXPRESSION IN CANCER
EP1776136B1 (en) 2004-06-24 2012-10-03 Biogen Idec MA Inc. Treatment of conditions involving demyelination
US10003762B2 (en) 2005-04-26 2018-06-19 Invention Science Fund I, Llc Shared image devices
US9093121B2 (en) 2006-02-28 2015-07-28 The Invention Science Fund I, Llc Data management of an audio data stream
MX2008000253A (es) 2005-07-08 2008-04-02 Biogen Idec Inc Anticuerpos de sp35 y usos de los mismos.
NZ590605A (en) 2008-07-09 2012-11-30 Biogen Idec Inc Compositions comprising antibodies to lingo or fragments thereof
CN102858962A (zh) 2009-11-19 2013-01-02 索利斯拜欧代因公司 用于增加多肽稳定性和活性的组合物及相关方法
KR102142161B1 (ko) 2012-05-14 2020-08-06 바이오젠 엠에이 인코포레이티드 운동 뉴런 관련 병태 치료용 lingo-2 길항제
MX2017009038A (es) 2015-01-08 2017-10-25 Biogen Ma Inc Antagonistas de proteina 1 de interacción con el receptor de nogo que contiene el dominio de inmunoglobulina y repeticiones ricas en leucina (lingo-1) y usos para el tratamiento de trastornos desmielinizantes.
CN119351338B (zh) * 2023-09-15 2026-01-23 士泽生物医药(苏州)有限公司 一种表达cd300ld的低免疫原性细胞及其制备方法
CN118108790B (zh) * 2024-03-25 2024-11-05 中国农业大学 一种具glp-1受体激动剂活性的乳清蛋白源降血糖肽的制备及应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0997476A3 (en) * 1998-09-25 2000-07-19 Schering-Plough Antibodies to a mammalian Langerhans cell antigen and their uses
AU2001243142A1 (en) * 2000-02-03 2001-08-14 Hyseq, Inc. Novel nucleic acids and polypeptides
US20020012967A1 (en) * 2000-03-10 2002-01-31 Holloway James L. Insulin homolog polypeptide zins4
CN1633498A (zh) * 2000-04-21 2005-06-29 武田药品工业株式会社 新型胰岛素/胰岛素样生长因子/松弛素家族多肽及其dna
JP3785029B2 (ja) * 2000-08-04 2006-06-14 株式会社山武 制御装置および制御方法
WO2002059312A2 (en) * 2000-12-18 2002-08-01 Incyte Genomics, Inc. Cell adhesion proteins
WO2002068649A2 (en) * 2001-01-31 2002-09-06 Curagen Corporation Proteins and nucleic acids encoding same
US6783969B1 (en) * 2001-03-05 2004-08-31 Nuvelo, Inc. Cathepsin V-like polypeptides

Also Published As

Publication number Publication date
HUP0400016A3 (en) 2006-01-30
KR20030033055A (ko) 2003-04-26
CZ2003722A3 (en) 2004-03-17
AU9261901A (en) 2002-03-26
US20070238151A1 (en) 2007-10-11
EP1317538A4 (en) 2005-04-06
HUP0400016A2 (hu) 2004-04-28
BR0113820A (pt) 2003-06-24
MXPA03002180A (es) 2004-12-13
CN1680441A (zh) 2005-10-12
IL154725A0 (en) 2003-10-31
IL154725A (en) 2003-12-23
NO20031141D0 (no) 2003-03-12
EP1317538A1 (en) 2003-06-11
CA2421303A1 (en) 2002-03-21
PL361691A1 (en) 2004-10-04
JP2004508825A (ja) 2004-03-25
NZ524328A (en) 2004-09-24
NZ534259A (en) 2006-05-26
AU2001292619B2 (en) 2006-01-12
WO2002022802A1 (en) 2002-03-21
CN1474869A (zh) 2004-02-11

Similar Documents

Publication Publication Date Title
NO20031141L (no) Nye forbindelser
NO20025151L (no) Nye forbindelser
PT1370571E (pt) Processos e aparelhos para analises qualitativas e quantitativas, isentas de gel, do proteoma e as suas utilizacoes
DK1259547T3 (da) Højpotente, rekombinante antistoffer og fremgangsmåde til fremstilling heraf
WO2002002636A3 (en) Membrane associated protein zupari
MXPA03000227A (es) Compuestos novedosos.
BRPI0418229A (pt) genes do ciclo celular e métodos corrrelatos de uso
WO2001066690A3 (en) Novel compounds
WO2001072961A3 (en) Novel compounds
NO20053595L (no) Escitalopramdibromid samt fremgangsmate ved fremstilling derav.
NO20005952D0 (no) Neisseria Meningitidis antigene polypeptider, korresponderende polynukleotider og beskyttende antistoffer
WO2002004600A3 (en) Novel compounds
DK1303539T3 (da) Hidtil ukendt medlem af EphA-receptorfamilien
DE60117788D1 (de) Menschliche wingless-änhliche gene
DK1257573T3 (da) Hidtil ukendt transskriptionsfaktor CARP-2
NO20016340L (no) Hodetraumeindusert cytoplasmatisk kalsiumbindende protein
DE60136643D1 (de) Neuromedin u delta polypeptide
EP0890646A3 (en) HE2NW40 Serine Protease
ATE443715T1 (de) Polypeptide aus haemophilus influenza
WO2002008252A3 (en) Novel protein containing ring finger domaine r1p4
WO2004020983A3 (en) Ultrafiltration device for drug binding studies
AU2001295600A1 (en) Novel compounds
DE60041074D1 (de) Spleissvariante des kopftrauma induzierten zytopla
AU6832300A (en) Novel compounds
WO2002074796A3 (en) Histidine phosphatase interacting protein with 240kd

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application